G. Pérez-Manga

发表

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

R. Schilsky, J. Marshall, P. Rougier, 2004, British Journal of Cancer.

International Recommendations for the Prevention and Treatment of Venous Thromboembolism Associated with Cancer

G. Pérez-Manga, P. Khosravi-Shahi, 2009, Clinical drug investigation.

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.

R. Schilsky, E. Van Cutsem, J. Marshall, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.

F. Calvo, G. Pérez-Manga, E. Alvarez, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

E. Van Cutsem, P. Rougier, W. Schmiegel, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Original Paper 'Tomudex' (ZD1694): Results ofa Randomised Trial in Advanced Colorectal Cancer Demonstrate Efficacy and Reduced Mucositis and Leucopenia

D. Kerr, D. Cunningham, I. Olver, 1995 .

'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group.

D. Kerr, E. Van Cutsem, J. Zalcberg, 1995, European journal of cancer.

Mediastinal Germ Cell Tumors

A. Roden, D. P. Perez Montiel, G. Pérez-Manga, 2017 .

Hepatic acetylator polymorphism in breast cancer patients.

C. Jara, G. Pérez-Manga, J. Ladero, 1987, Oncology.

Short report Final results of a randomised trial comparing Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

J. Zalcberg, C. Svensson, G. Pérez-Manga, 2005 .

Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trial.

J. Garcia-conde, A. Lluch, D. Khayat, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffuse large B-cell lymphoma in the older.

G. Pérez-Manga, A. Gutiérrez, J. Rodriguez, 2011, Critical reviews in oncology/hematology.

Primary renal lymphoma: report of 3 cases and review of the literature.

G. Pérez-Manga, A. Tejedor, J. A. Arranz Arija, 1994, American journal of nephrology.

Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.

B. Martínez-Delgado, G. Pérez-Manga, A. Gutiérrez, 2009, Critical reviews in oncology/hematology.

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.

P. Zamora, R. Colomer, G. Pérez-Manga, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group

G. Pérez-Manga, E. González-Flores, P Garcia-Alfonso, 2009, British Journal of Cancer.

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer

A. Ruíz, M. Söderberg, M. González Barón, 2004, British Journal of Cancer.

Hematopoietic SCT for peripheral T-cell lymphoma

G. Pérez-Manga, A. Gutiérrez, M. Caballero, 2008, Bone Marrow Transplantation.

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group.

D. Kerr, E. Van Cutsem, J. Zalcberg, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

M. Benavides, F. Carabantes, G. Pérez-Manga, 2004, Medical oncology.

Oral Capeci tabine Compared With Intravenous Fluorourac i l Plus Leucovor in in Pat ients With Metastat ic Colorecta l Cancer : Resul ts of a Large Phase III Study

P. Rougier, W. Schmiegel, C. Weitzel, 2001 .